Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Mutational load distribution analysis (MLDA) in pancreatic cancer

Mutational load distribution analysis (MLDA) in pancreatic cancer

82
Lynch, HenryCreighton University

No coordinating investigator defined.

Ki-ras
UNKNOWN
G.I. and Other Associated Cancers Research Group

Certain p16 mutation carriers showed mutation elevations in the specific Ki-ras and p53 alleles significantly higher than normal, similar to controls with pancreatitis. Two individuals from separate families started out with "low risk" readings subsequently converted to "high risk" categorization and remained there in each sequential exam.

No datasets are currently associated with this protocol.


Announcement 6/2/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.

Announcement 6/1/2018

Dr. Sudhir Srivastava was honored with the 2017 Human Proteome Organization (HUPO) Award for a Distinguished Scientist in Clinical and Translational Proteomics. Please join us in congratulating him on his accomplishments and contributions. The awards were presented at HUPO 2017 in Dublin, Ireland and the winners were present to provide a small talk during the Awards Ceremony and HUPO Lectures.